Background: A biomarker that is of great interest in relation to adverse cardiovascular events is soluble ST2 (sST2), a member of the interleukin family. Considering that metabolic syndrome (MetS) is accompanied by a proinflammatory state, we aimed to assess the relationship between sST2 and left ventricular (LV) structure and function in patients with MetS. Methods: A multicentric, cross-sectional study was conducted on180 MetS subjects with normal LV ejection fraction as determined by echocardiography. LV hypertrophy (LVH) was defined as an LV mass index greater than the gender-specific upper limit of normal as determined by echocardiography. LV diastolic dysfunction (DD) was assessed by pulse-wave and tissue Doppler imaging. sST2 was measured by using a quantitative monoclonal ELISA assay. Results: LV mass index (β=0.337, P<0 .001, linear regression) was independently associated with sST2 concentrations. Increased sST2 was associated with an increased likelihood of LVH [Exp (B)=2.20, P=0.048, logistic regression] and increased systolic blood pressure [Exp (B)=1.02, P=0.05, logistic regression]. Comparing mean sST2 concentrations (adjusted for age, body mass index, gender) between different LV remodeling patterns, we found the greatest sST2 level in the group with concentric hypertrophy. There were no differences in sST2 concentration between groups with and without LV DD. Conclusions: Increased sST2 concentration in patients with MetS was associated with a greater likelihood of exhibiting LVH. Our results suggest that inflammation could be one of the principal triggering mechanisms for LV remodeling in MetS.

Soluble ST2 levels and left ventricular structure and function in patients with metabolic syndrome / Celic, Vera; Majstorovic, Anka; Pencic-Popovic, Biljana; Sljivic, Aleksandra; Lopez-Andres, Natalia; Roy, Ignacio; Escribano, Elena; Beunza, Maite; Melero, Amaia; Floridi, Federico; Magrini, Laura; Marino, Rossella; Salerno, Gerardo; Cardelli, Patrizia; Di Somma, Salvatore. - In: ANNALS OF LABORATORY MEDICINE. - ISSN 2234-3806. - ELETTRONICO. - 36:6(2016), pp. 542-549. [10.3343/alm.2016.36.6.542]

Soluble ST2 levels and left ventricular structure and function in patients with metabolic syndrome

Marino, Rossella;Salerno, Gerardo;Cardelli, Patrizia;Di Somma, Salvatore
2016

Abstract

Background: A biomarker that is of great interest in relation to adverse cardiovascular events is soluble ST2 (sST2), a member of the interleukin family. Considering that metabolic syndrome (MetS) is accompanied by a proinflammatory state, we aimed to assess the relationship between sST2 and left ventricular (LV) structure and function in patients with MetS. Methods: A multicentric, cross-sectional study was conducted on180 MetS subjects with normal LV ejection fraction as determined by echocardiography. LV hypertrophy (LVH) was defined as an LV mass index greater than the gender-specific upper limit of normal as determined by echocardiography. LV diastolic dysfunction (DD) was assessed by pulse-wave and tissue Doppler imaging. sST2 was measured by using a quantitative monoclonal ELISA assay. Results: LV mass index (β=0.337, P<0 .001, linear regression) was independently associated with sST2 concentrations. Increased sST2 was associated with an increased likelihood of LVH [Exp (B)=2.20, P=0.048, logistic regression] and increased systolic blood pressure [Exp (B)=1.02, P=0.05, logistic regression]. Comparing mean sST2 concentrations (adjusted for age, body mass index, gender) between different LV remodeling patterns, we found the greatest sST2 level in the group with concentric hypertrophy. There were no differences in sST2 concentration between groups with and without LV DD. Conclusions: Increased sST2 concentration in patients with MetS was associated with a greater likelihood of exhibiting LVH. Our results suggest that inflammation could be one of the principal triggering mechanisms for LV remodeling in MetS.
2016
echocardiography; left ventricular hypertrophy; metabolic syndrome; soluble st2; clinical biochemistry; biochemistry (medical)
01 Pubblicazione su rivista::01a Articolo in rivista
Soluble ST2 levels and left ventricular structure and function in patients with metabolic syndrome / Celic, Vera; Majstorovic, Anka; Pencic-Popovic, Biljana; Sljivic, Aleksandra; Lopez-Andres, Natalia; Roy, Ignacio; Escribano, Elena; Beunza, Maite; Melero, Amaia; Floridi, Federico; Magrini, Laura; Marino, Rossella; Salerno, Gerardo; Cardelli, Patrizia; Di Somma, Salvatore. - In: ANNALS OF LABORATORY MEDICINE. - ISSN 2234-3806. - ELETTRONICO. - 36:6(2016), pp. 542-549. [10.3343/alm.2016.36.6.542]
File allegati a questo prodotto
File Dimensione Formato  
Celic_Soluble-ST2_2016.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Creative commons
Dimensione 239.89 kB
Formato Adobe PDF
239.89 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/895808
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 9
social impact